Persistent Benefit News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Persistent Benefit. Real-time updates on events, politics, business and more.

Synaptogenix President Daniel L. Alkon, M.D. Honored for Scientific Presentation at USC-Sponsored Forum on Age-Related Diseases and Neurodegenerative Disorders

December 19, 2023

Bryostatin-1 benefits in severe Alzheimers disease patients were statistically significant with respect to placebo at p

Source: marketscreener.com

October 16, 2023

Patients with severe Alzheimer's Disease (AD) showed no cognitive decline throughout a ten-month trial while being treated with Bryostatin-1.

Source: outsourcing-pharma.com